bf/NASDAQ:BIOL_icon.jpeg

COM:BIOLASE

BIOLASE

  • Stock

Last Close

0.02

02/10 20:00

Market Cap

2.84M

Beta: -

Volume Today

2.67M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
11.26M
-
11.94M
6.07%
12.54M
4.97%
13.04M
4.05%
12.91M
1.03%
12.27M
4.94%
11.62M
5.31%
11.08M
4.69%
12.04M
8.73%
14.41M
19.63%
13.66M
5.19%
average payables
8.11M
-
8.46M
4.28%
7.16M
15.37%
7.54M
5.36%
7.12M
5.64%
5.53M
22.28%
5.64M
2.02%
3.99M
29.26%
2.98M
25.34%
4.55M
52.60%
5.93M
30.30%
average receivables
11.40M
-
10.07M
11.73%
8.98M
10.82%
9.37M
4.34%
9.95M
6.28%
10.62M
6.67%
9.94M
6.42%
5.91M
40.52%
3.65M
38.26%
5.04M
38.13%
5.66M
12.35%
book value per share
3.04K
-
11.69K
284.69%
5.35K
54.18%
4.55K
15.09%
4.96K
9.08%
1.35K
72.85%
0.41
99.97%
4.10
909.63%
4.27
4.00%
0.71
83.46%
-0.19
127.40%
capex per share
-245.34
-
-55.02
77.58%
-387.33
604.03%
-291.37
24.77%
-126.61
56.55%
-67.76
46.48%
-0.22
99.67%
-0.04
82.40%
-0.12
204.68%
-0.54
349.57%
-1.03
90.74%
capex to depreciation
-1.14
-
-0.28
75.04%
-2.05
620.21%
-1.35
34.15%
-0.62
53.98%
-0.59
4.91%
-0.21
64.30%
-0.19
8.73%
-1.77
818.73%
-7.50
324.27%
-0.47
93.75%
capex to operating cash flow
0.07
-
0.01
83.41%
0.10
730.11%
0.13
30.91%
0.04
69.45%
0.04
2.78%
0.02
58.83%
0.01
53.80%
0.04
463.91%
0.14
229.17%
0.09
33.20%
capex to revenue
-0.01
-
-0.00
65.77%
-0.04
795.22%
-0.03
26.62%
-0.02
41.67%
-0.01
24.05%
-0.01
54.70%
-0.00
23.05%
-0.02
328.10%
-0.08
326.28%
-0.03
65.33%
cash per share
515.76
-
8.77K
1,600.23%
2.51K
71.34%
1.84K
26.83%
1.97K
7.33%
976.81
50.51%
6.24
99.36%
7.18
15.16%
5.07
29.40%
0.60
88.10%
5.14
751.58%
days of inventory on hand
119.00
-
154.84
30.13%
141.02
8.93%
156.69
11.11%
141.16
9.91%
152.79
8.24%
170.69
11.72%
245.22
43.66%
208.27
15.07%
178.11
14.48%
128.64
27.78%
days payables outstanding
89.52
-
103.46
15.56%
66.88
35.35%
105.73
58.08%
58.64
44.54%
74.26
26.63%
82.78
11.47%
58.27
29.61%
53.30
8.52%
64.88
21.72%
68.24
5.18%
days sales outstanding
71.97
-
68.96
4.18%
67.38
2.30%
68.93
2.30%
78.75
14.24%
87.88
11.59%
84.59
3.74%
49.01
42.06%
39.47
19.47%
43.99
11.45%
40.71
7.47%
debt to assets
0.15
-
0.01
-
0.02
188.00%
0.00
92.67%
0.28
17,209.22%
0.56
96.90%
0.45
19.78%
0.28
37.20%
0.39
40.96%
0.49
23.88%
debt to equity
0.55
-
0.01
-
0.04
222.95%
0.00
94.34%
0.98
40,825.48%
46.89
4,688.78%
1.82
96.12%
0.61
66.33%
3.08
402.03%
-69.38
2,353.96%
dividend yield
0.01
-
0.00
98.60%
0.00
408.41%
earnings yield
-0.12
-
-0.16
36.91%
-0.41
159.36%
-0.18
56.37%
-0.53
193.59%
-1.06
98.67%
-0.01
98.67%
-0.01
53.15%
-0.00
57.22%
-0.06
2,166.94%
-14.41
22,575.51%
enterprise value
101.47M
-
86.76M
14.50%
37.34M
56.96%
76.16M
103.98%
20.07M
73.65%
23.17M
15.48%
1.28B
5,439.63%
2.57B
100.01%
5.75B
123.84%
461.32M
91.97%
12.78M
97.23%
enterprise value over ebitda
-9.23
-
-4.84
47.60%
-1.77
63.44%
-5.61
217.16%
-1.22
78.16%
-1.34
9.68%
-87.69
6,429.56%
-185.77
111.84%
-365.70
96.86%
-18.57
94.92%
-0.84
95.46%
ev to operating cash flow
-10.92
-
-5.36
50.94%
-2.10
60.77%
-7.15
240.49%
-1.09
84.76%
-1.64
50.29%
-100.72
6,048.52%
-200.68
99.25%
-343.95
71.39%
-17.24
94.99%
-0.91
94.74%
ev to sales
1.80
-
1.82
1.24%
0.77
57.69%
1.47
90.85%
0.43
70.91%
0.50
17.41%
33.96
6,664.24%
112.71
231.88%
146.66
30.12%
9.52
93.51%
0.26
97.27%
free cash flow per share
-3.57K
-
-4.56K
27.46%
-4.21K
7.71%
-2.49K
40.90%
-3.25K
30.66%
-1.79K
45.01%
-13.96
99.22%
-5.27
62.23%
-2.95
44.10%
-4.40
49.28%
-12.05
173.94%
free cash flow yield
-0.10
-
-0.14
36.47%
-0.40
188.95%
-0.14
64.54%
-0.60
325.41%
-0.72
19.42%
-0.01
98.59%
-0.01
50.53%
-0.00
39.80%
-0.07
2,139.24%
-10.76
15,798.12%
graham net net
-2.54K
-
7.56K
398.14%
1.58K
79.08%
648.57
59.02%
1.98K
204.79%
-598.06
130.25%
-14.67
97.55%
-2.27
84.50%
1.61
170.97%
-2.42
250.14%
-14.83
512.00%
graham number
16.77K
-
37.18K
121.79%
22.91K
38.39%
18.00K
21.43%
17.85K
0.82%
8.90K
50.16%
13.26
99.85%
25.20
90.05%
16.20
35.73%
8.10
50.00%
8.38
3.46%
income quality
0.81
-
0.86
5.73%
0.88
2.38%
0.69
20.97%
1.09
57.74%
0.66
39.82%
0.71
8.57%
0.76
6.50%
1.03
36.02%
0.93
9.63%
0.68
26.92%
intangibles to total assets
0.10
-
0.05
48.91%
0.07
37.68%
0.07
0.99%
0.07
2.43%
0.08
11.60%
0.09
20.94%
0.07
22.37%
0.05
25.79%
0.08
44.78%
0.08
8.79%
interest coverage
-18.33
-
-39.17
113.75%
36.47
193.11%
-57.99
258.99%
180.38
411.04%
-40.95
122.70%
-7.24
82.32%
-7.86
8.50%
-7.25
7.78%
-9.22
27.20%
-7.60
17.58%
interest debt per share
1.87K
-
127.26
93.21%
-47.26
137.14%
245.21
618.84%
-5.08
102.07%
1.38K
27,246.45%
21.37
98.45%
8.44
60.53%
2.99
64.53%
2.57
14.15%
15.26
494.04%
inventory turnover
3.07
-
2.36
23.15%
2.59
9.80%
2.33
10.00%
2.59
11.00%
2.39
7.61%
2.14
10.49%
1.49
30.39%
1.75
17.74%
2.05
16.93%
2.84
38.46%
invested capital
0.55
-
0.01
-
0.04
222.95%
0.00
94.34%
0.98
40,825.48%
46.89
4,688.78%
1.82
96.12%
0.61
66.33%
3.08
402.03%
-69.38
2,353.96%
market cap
98.28M
-
118.32M
20.39%
48.88M
58.69%
84.93M
73.76%
31.71M
62.66%
20.38M
35.73%
1.28B
6,160.81%
2.57B
101.19%
5.76B
124.45%
450.45M
92.18%
1.43M
99.68%
net current asset value
3.30M
-
37.45M
1,035.91%
17.47M
53.34%
14.11M
19.25%
22.33M
58.22%
5.88M
73.66%
-4.45M
175.70%
4.11M
192.41%
19.28M
368.71%
-4.34M
122.50%
-10.48M
141.70%
net debt to ebitda
-0.29
-
1.76
705.80%
0.55
68.94%
0.65
18.10%
0.71
10.11%
-0.16
122.77%
-0.52
224.10%
-0.03
94.54%
0.95
3,413.62%
-0.44
146.09%
-0.75
71.26%
net income per share
-4.11K
-
-5.26K
27.87%
-4.36K
17.16%
-3.17K
27.29%
-2.86K
9.83%
-2.61K
8.52%
-19.24
99.26%
-6.88
64.22%
-2.73
60.28%
-4.13
51.13%
-16.14
290.72%
operating cash flow per share
-3.33K
-
-4.50K
35.20%
-3.82K
15.19%
-2.19K
42.54%
-3.12K
42.24%
-1.72K
44.95%
-13.73
99.20%
-5.23
61.90%
-2.83
45.97%
-3.86
36.58%
-11.03
185.52%
payables turnover
4.08
-
3.53
13.47%
5.46
54.68%
3.45
36.74%
6.22
80.30%
4.92
21.03%
4.41
10.29%
6.26
42.07%
6.85
9.31%
5.63
17.84%
5.35
4.93%
receivables turnover
5.07
-
5.29
4.36%
5.42
2.36%
5.30
2.25%
4.64
12.47%
4.15
10.39%
4.31
3.88%
7.45
72.58%
9.25
24.17%
8.30
10.27%
8.97
8.07%
research and ddevelopement to revenue
0.07
-
0.10
34.52%
0.15
56.43%
0.15
0.19%
0.13
11.82%
0.11
15.08%
0.13
11.83%
0.16
28.67%
0.15
4.85%
0.15
2.87%
0.12
18.54%
return on tangible assets
-0.41
-
-0.34
18.32%
-0.52
53.76%
-0.39
23.70%
-0.42
6.77%
-0.60
43.71%
-0.62
2.12%
-0.44
28.45%
-0.31
30.13%
-0.81
163.15%
-0.64
21.04%
revenue per share
20.21K
-
13.24K
34.48%
10.41K
21.36%
10.68K
2.52%
7.95K
25.50%
5.60K
29.53%
40.73
99.27%
9.32
77.12%
6.63
28.83%
6.99
5.46%
38.47
450.11%
roe
-1.35
-
-0.45
66.76%
-0.81
80.78%
-0.70
14.37%
-0.58
17.33%
-1.94
236.91%
-47.36
2,340.90%
-1.68
96.46%
-0.64
61.81%
-5.86
813.72%
83.53
1,526.21%
roic
-0.83
-
-0.43
48.09%
-0.79
84.25%
-0.65
17.47%
-0.59
8.90%
-0.95
60.55%
-0.85
11.15%
-0.62
26.74%
-0.38
38.15%
-1.20
212.29%
-1.02
15.24%
sales general and administrative to revenue
0.17
-
0.31
87.57%
0.21
32.12%
0.20
4.64%
0.21
2.58%
0.26
23.23%
0.28
11.49%
0.43
50.86%
0.29
33.03%
0.25
11.59%
0.21
18.19%
shareholders equity per share
3.04K
-
11.69K
284.69%
5.35K
54.18%
4.55K
15.09%
4.96K
9.08%
1.35K
72.85%
0.41
99.97%
4.10
909.63%
4.27
4.00%
0.71
83.46%
-0.19
127.40%
stock based compensation to revenue
0.03
-
0.03
14.87%
0.07
167.10%
0.06
14.40%
0.05
20.50%
0.06
27.51%
0.07
20.96%
0.15
103.93%
0.04
71.33%
0.05
12.05%
0.03
47.27%
tangible asset value
5.37M
-
39.02M
626.28%
21.95M
43.75%
19.14M
12.80%
26.33M
37.59%
8.16M
69.00%
-2.55M
131.23%
7.10M
378.62%
22.28M
213.74%
1.96M
91.19%
-3.17M
261.64%
tangible book value per share
1.92K
-
10.84K
463.43%
4.71K
56.51%
3.94K
16.36%
4.46K
13.18%
991.26
77.79%
-2.75
100.28%
2.90
205.75%
3.77
29.80%
0.28
92.49%
-2.48
976.50%
working capital
3.92M
-
38.65M
887.15%
19.69M
49.04%
15.97M
18.89%
22.68M
41.99%
17.34M
23.54%
1.24M
92.85%
23.89M
1,826.37%
35.51M
48.66%
11.15M
68.59%
5.20M
53.37%

All numbers in (except ratios and percentages)